Brian Casey

Microbiology
LabPulse.com Microbiology Insider
Dear Microbiology Insider,
May 17, 2022
Alzheimer's
FDA grants approval for Fujirebio assay for Alzheimer's plaques
The FDA granted clearance under its breakthrough device pathway to Fujirebio's Lumipulse G β-Amyloid Ratio (1-42/1-40) test, which is designed to measure the ratio of β-amyloid 1-42 and β-amyloid 1-40. These are proteins that can accumulate and form plaques in the brain; concentrations of these proteins can be detected in cerebral spinal fluid (CSF).
May 3, 2022
2022 05 04 20 54 3251 Computer Brain Hemisphere 400
Moderate Complexity Test
FDA tightens policy on reviews of lab-developed tests
In a November 15 press release, the FDA said it was withdrawing its policy that directed the agency to not enforce premarket review requirements for LDTs. The agency said it was taking the action to "help ensure that COVID-19 tests are accurate and reliable."
November 14, 2021
2020 03 18 20 13 7386 Virus Coronavirus Covid 19 400
Plague
House probe says Trump officials changed COVID-19 testing rules
In a November 12 press release, the House select subcommittee on the coronavirus crisis included a critique of the performance of neuroradiologist Dr. Scott Atlas as President Trump's special advisor on dealing with the pandemic. The subcommittee, chaired by Rep. James Clyburn (D-SC), is investigating allegations that the U.S. government's response to the pandemic was undermined for political reasons by the Trump administration.
November 14, 2021
2020 07 01 22 14 2802 Washington Dc Capitol 400
Home
Biden taps Califf to once again lead FDA as commissioner
Califf was a longtime professor at Duke University, where he earned his medical degree in 1978. He was vice president of clinical and translational research at Duke for 16 years; his most immediate position has been senior advisor at Verily Life Sciences and Google Health.NEW: This morning @califf001 will be announced as the new FDA Commissioner.No other choice brings both continuity & exciting new direction at such an important time.
November 11, 2021
2021 11 12 18 02 7119 Califf Robert 20211112183706
Microbiology
LabPulse.com Microbiology Insider
Dear Microbiology Insider,
August 31, 2021
Sequencing
Illumina completes Grail deal, despite lack of European approval
Illumina announced its intent to acquire Grail in September 2020 for $8 billion in cash and stock. The deal would unite Illumina's core expertise in next-generation sequencing (NGS) with Grail's diagnostic portfolio, specifically the Galleri test for more than 50 types of cancer. The deal reunites Grail with Illumina, which spun off Grail four years ago.
August 17, 2021
2020 01 09 22 46 7361 Business Deal Corporate 400
Infectious
With Hitachi deal done, Fujifilm sets sights on healthcare growth
The company's European business will be known as Fujifilm Healthcare Europe, while the U.S. unit has been renamed as Fujifilm Healthcare Americas. The new business will offer a complete line of medical products representing both Fujifilm and Hitachi portfolios.
July 1, 2021
2021 03 18 23 58 5869 Fujifilm Rsna 2019 400
FDA Warning Letter
FDA puts kibosh on use of Innova Medical coronavirus test
In a June 10 notice, the FDA said it had "significant concerns" that the performance of Innova's SARS-CoV-2 Antigen Rapid Qualitative Test had not been proven in clinical studies. Also, the FDA noted that the test had not been authorized or cleared by the agency for commercial distribution in the U.S.
June 9, 2021
2019 02 13 19 24 5396 Fda Logo V2 400
Pathology, histology
VA inquiry finds Ark. pathology chief made 3K errors
Levy was chief of pathology and laboratory medicine at Veterans Health Care System of the Ozarks in Fayetteville until he was terminated in 2018, two years after he had completed a substance abuse program that was ordered after he was accused of working under the influence of alcohol.
June 1, 2021
2021 06 02 20 19 9323 Business Computer Investigation Magnifying Glass 400
Page 1 of 6
Next Page
Top Stories
Test Tube Liquid Sample Social
Agreement
BioMérieux subsidiary secures DoD contract for infectious disease testing system
BioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.
Cigarette Smoking Social
Schizophrenia
Genetic predisposition to smoking may drive schizophrenia heart disease risk: Study
Artificial Intelligence Drug Design Funding Social
Financing
Harbinger Health raises $140M in series B funding
Plasmodium Falciparum Malaria Cdc Social
Malaria
Study shows malaria drug resistance occurring in Horn of Africa
Latest in at-home or lab-based STI testing
Sponsor Content
Latest in at-home or lab-based STI testing
More in Home
BioMérieux subsidiary secures DoD contract for infectious disease testing system
BioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.
September 29, 2023
Test Tube Liquid Sample Social
Genetic predisposition to smoking may drive schizophrenia heart disease risk: Study
Genetic factors are unlikely to directly drive the increased rate of cardiovascular disease in schizophrenia patients but may influence lifestyle, according to a paper in the American Journal of Psychiatry.
September 29, 2023
Cigarette Smoking Social
Harbinger Health raises $140M in series B funding
Biotech company Harbinger Health has raised $140 million in a series B funding round.
September 29, 2023
Artificial Intelligence Drug Design Funding Social
Study shows malaria drug resistance occurring in Horn of Africa
Malaria parasites in eastern Africa have developed resistance to artemisinins, essential first-line drugs used in combination therapies, jeopardizing the progress made in recent decades against the disease.
September 29, 2023
Plasmodium Falciparum Malaria Cdc Social
Day Zero Diagnostics to use $16M in funding to improve management of antibiotic-resistant infections
Day Zero Diagnostics recently raised $16 million to fund the application of whole-genome sequencing and artificial intelligence to antibiotic-resistant infections, facilitating the firm’s goal of changing how infectious diseases are diagnosed.
September 28, 2023
Dna Sequencing2
U.S. Attorney’s Office wins $370M judgment in Medicare fraud case
The U.S. Attorney's Office for the Middle District of Florida won a $370 million default judgment against a Kentucky lab owner and his businesses for a lab testing scheme intended to defraud Medicare.
September 28, 2023
Gavel Money Social
Ginkgo Bioworks, Pfizer collaborate on RNA-based therapeutics
Cell engineering company Ginkgo Bioworks has entered into an agreement with Pfizer to discover and develop RNA-based drug candidates.
September 28, 2023
Rna Strand Social
Study launched on early intervention with immune modulators in COVID-19
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
September 26, 2023
Coronavirus Covid Blue Social
U.S. government investing $600M in COVID-19 test manufacturing
The U.S. Department of Health and Human Services announced that it is investing $600 million in funding into COVID-19 test manufacturing.
September 26, 2023
Dollar Money Coronavirus Mask Social
Some emergency sepsis screening tools inadequate, EU study suggests
Two out of the four internationally recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, say German researchers.
September 26, 2023
Sepsis Bacteria Social
Thermo Fisher Scientific prepared to expand its work at manufacturing facility
Thermo Fisher Scientific executives voiced hopes for expanding work to help combat diseases at its giant $180 million viral vector manufacturing site in Plainville, MA.
September 27, 2023
Manufacturing Facility Process Social
HIV vaccine trial begins enrollment in U.S., South Africa
A clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.
September 25, 2023
Vial Vaccine Vial Tech Social
Page 1 of 92
Next Page